Co-Diagnostics Long Term Debt 2017-2024 | CODX
Co-Diagnostics Annual Long Term Debt (Millions of US $) |
|
---|---|
2023 | $ |
2022 | $ |
2021 | $ |
2020 | $ |
2019 | $ |
2018 | $ |
2017 | $ |
2016 | $0 |
Co-Diagnostics Quarterly Long Term Debt (Millions of US $) |
|
---|---|
2024-09-30 | |
2024-06-30 | |
2024-03-31 | |
2023-12-31 | |
2023-09-30 | |
2023-06-30 | |
2023-03-31 | |
2022-12-31 | |
2022-09-30 | |
2022-06-30 | |
2022-03-31 | |
2021-12-31 | |
2021-09-30 | |
2021-06-30 | |
2021-03-31 | |
2020-12-31 | |
2020-09-30 | |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | |
2019-09-30 | |
2019-06-30 | |
2019-03-31 | |
2018-12-31 | |
2018-09-30 | |
2018-06-30 | |
2018-03-31 | |
2017-12-31 | |
2017-09-30 | |
2017-06-30 | |
2017-03-31 | |
2016-12-31 | |
2016-09-30 | |
2016-06-30 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.010B | $0.004B |
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $146.516B | 27.37 |
Elevance Health (ELV) | United States | $98.469B | 13.19 |
CVS Health (CVS) | United States | $85.419B | 12.50 |
Cencora (COR) | United States | $53.926B | 19.57 |
DiDi Global (DIDIY) | China | $23.525B | 0.00 |
Natera (NTRA) | United States | $19.117B | 0.00 |
BioMerieux (BMXMF) | France | $14.914B | 0.00 |
ICON (ICLR) | Ireland | $14.132B | 12.84 |
Solventum (SOLV) | United States | $13.154B | 12.27 |
Revvity (RVTY) | United States | $12.712B | 21.59 |
Avantor (AVTR) | United States | $11.045B | 16.21 |
CochLear (CHEOY) | Australia | $10.877B | 0.00 |
Doximity (DOCS) | United States | $10.834B | 56.34 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
Viatris (VTRS) | United States | $10.397B | 3.29 |
Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
HealthEquity (HQY) | United States | $7.644B | 37.60 |
Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
Organon (OGN) | United States | $3.841B | 3.91 |
Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
Sotera Health (SHC) | United States | $3.305B | 19.11 |
BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
Concentras Parent (CON) | United States | $2.781B | 14.47 |
GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
Progyny (PGNY) | United States | $1.908B | 42.15 |
Agilon Health (AGL) | United States | $1.785B | 0.00 |
Premier (PINC) | United States | $1.760B | 11.27 |
PACS (PACS) | United States | $1.713B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
CareDx (CDNA) | United States | $0.984B | 16.75 |
AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
Embecta (EMBC) | United States | $0.741B | 5.08 |
QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
Enhabit (EHAB) | United States | $0.444B | 41.86 |
Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
SBC Medicals (SBC) | United States | $0.329B | 0.00 |
DocGo (DCGO) | United States | $0.269B | 11.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
Nutex Health (NUTX) | United States | $0.256B | 5.10 |
LifeMD (LFMD) | United States | $0.243B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
Beauty Health (SKIN) | United States | $0.168B | 0.00 |
Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
So-Young (SY) | China | $0.098B | 0.00 |
Biodesix (BDSX) | United States | $0.091B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
OncoCyte (OCX) | United States | $0.088B | 0.00 |
Oncology Institute (TOI) | United States | $0.086B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
NeueHealth (NEUE) | United States | $0.056B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
ModivCare (MODV) | United States | $0.019B | 6.57 |
SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
KindlyMD (KDLY) | United States | $0.010B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.001B | 0.00 |
Aclarion (ACON) | United States | $0.000B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |